Viewing Study NCT00078234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-01-01 @ 3:36 AM
Study NCT ID: NCT00078234
Status: COMPLETED
Last Update Posted: 2011-11-07
First Post: 2004-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia
Sponsor: Genta Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None Leukemia View
None Chronic View
None Cancer View
None Adult View
None Lymphocytic View
None Genasense View
None G3139 View
None Genta View
None Bcl-2 View
None Antisense View
None Oligonucleotide View
None oblimersen View